Biocon Biologics signs agreement to expand access of cancer biosimilars to over 30 countries
Biocon Biologics signs agreement to expand access of cancer biosimilars to over 30 countries

Biocon Biologics signs agreement to expand access of cancer biosimilars to over 30 countries

Anthony Fernandes Article rating: 4.3

Biocon Biologics, a fully-integrated biosimilars company and a subsidiary of Biocon Limited announced that it has signed an agreement with Clinton Health Access Initiative to expand access to lifesaving cancer biosimilars in over 30 countries in Africa and Asia as a part of Cancer Access Partnership (CAP).   

Know why one needs to exercise caution in BHEL despite witnessing outperformance
Know why one needs to exercise caution in BHEL despite witnessing outperformance

Know why one needs to exercise caution in BHEL despite witnessing outperformance

Karan Dsij Article rating: 4.6

Given the fact that the stock has started to outperform in the recent past on the back of a huge volume spike certainly indicates interest for this stock; however, it has reached a very crucial juncture. This juncture is known as a ‘change in polarity’. The principle of change in polarity states that once breached, a support level becomes resistance and vice-versa i.e. the resistance level becomes support. 

These stocks are witnessing spike in delivery volumes!
These stocks are witnessing spike in delivery volumes!

These stocks are witnessing spike in delivery volumes!

Karan Dsij Article rating: 4.0

One of the most crucial things that many of the market participants tend to overlook when they buy a stock for a short-term trading purpose or for an investment purpose is the delivery volume. The stocks that are a part of Nifty 500 are considered and the total volume traded should be greater than 1,00,000. Further, the total volume traded should be greater than the previous session.

BEL signs MoU with BPL Medical Technologies
BEL signs MoU with BPL Medical Technologies

BEL signs MoU with BPL Medical Technologies

Chinmayee D Article rating: 4.0

The company will leverage policy initiatives of the Indian Government, such as ‘Make in India’ to offer affordable healthcare for the country. 

Brazil subsidiary of Kalpataru Power Transmission to acquire 51 per cent stake in Fasttel
Brazil subsidiary of Kalpataru Power Transmission to acquire 51 per cent stake in Fasttel

Brazil subsidiary of Kalpataru Power Transmission to acquire 51 per cent stake in Fasttel

Apurva Joshi Article rating: 4.9

Kalpataru Power Transmission Limited’s (KPTL) wholly-owned subsidiary in Brazil namely, Kalpataru Power do Brasil Participações Ltda has signed definitive agreement to acquire a controlling stake of 51 per cent in Fasttel Engenharia Ltda, Brazil (Fasttel) for ~USD 8.80 million.

RSS
First19671968196919701972197419751976Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR